A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo
10.1371/journal.pone.0042120
Saved in:
Main Authors: | Petty, A., Myshkin, E., Qin, H., Guo, H., Miao, H., Tochtrop, G.P., Hsieh, J.-T., Page, P., Liu, L., Lindner, D.J., Acharya, C., MacKerell Jr., A.D., Ficker, E., Song, J., Wang, B. |
---|---|
Other Authors: | BIOLOGICAL SCIENCES |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/99967 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Dynamic principle for designing antagonistic/agonistic molecules for EphA4 receptor, the only known ALS modifier
by: Qin, Haina, et al.
Published: (2016) -
Structural characterization of the EphA4-ephrin-B2 complex reveals new features enabling Eph-ephrin binding promiscuity
by: Qin, H., et al.
Published: (2011) -
Evidence That the EphA2 Receptor Exacerbates Ischemic Brain Injury
by: Thundyil J., et al.
Published: (2018) -
Distinctive binding of three antagonistic peptides to the ephrin-binding pocket of the EphA4 receptor
by: Lamberto, I., et al.
Published: (2014) -
Single-cell analysis of EphA clustering phenotypes to probe cancer cell heterogeneity
by: Ravasio, Andrea, et al.
Published: (2021)